[1] |
孟娟红, 甘业华, 马绪臣. 颞下颌关节骨关节炎发病的分子机制及相关治疗的实验研究[J]. 北京大学学报(医学版), 2013, 45(1): 5-8.
|
[2] |
Haigler MC, Abdulrehman E, Siddappa S, et al. Use of platelet-rich plasma, platelet-rich growth factor with arthrocentesis or arthroscopy to treat temporomandibular joint osteoarthritis: Systematic review with meta-analyses[J]. J Am Dent Assoc, 2018, 149(11): 940-952.e2.
doi: S0002-8177(18)30575-0
pmid: 30724168
|
[3] |
Saravanan D, Rethinam S, Muthu K, et al. The combined effect of bioactive glass and platelet-rich fibrin in treating human periodontal intrabony defects—A clinicoradiographic study[J]. Contemp Clin Dent, 2019, 10(1): 110-116.
doi: 10.4103/ccd.ccd_507_18
URL
|
[4] |
马绪臣. 颞下颌关节病的基础与临床[M]. 2版. 北京: 人民卫生出版社, 2004: 113-114.
|
[5] |
蔡琦, 李松, 焦国良. 颞下颌关节骨关节病影像学诊断研究进展[J]. 口腔颌面修复学杂志, 2017, 18(4): 250-254.
|
[6] |
Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation[J]. J Oral Maxillofac Surg, 2000, 58(3): 297-300;
doi: 10.1016/S0278-2391(00)90058-2
URL
|
[7] |
辛蔚妮, 凌均棨. 《口腔健康影响程度量表(OHIP-14中文版)》与《老年口腔健康评价指数(GOHAI中文版)》的比较研究[J]. 口腔医学研究, 2014, 30(3): 252-257.
|
[8] |
Triantaffilidou K, Venetis G, Bika O. Efficacy of hyaluronic acid injections in patients with osteoarthritis of the temporomandibular joint. A comparative study[J]. J Craniofac Surg, 2013, 24(6): 2006-2009.
doi: 10.1097/SCS.0b013e3182a30566
pmid: 24220392
|
[9] |
孙玉环, 何冬梅. 颞下颌关节创伤性骨关节炎及其发病机制研究进展[J]. 中国实用口腔科杂志, 2013, 6(6): 370-374.
|
[10] |
张清彬, 管红兵. 颞下颌关节紊乱病的“梯度序列治疗”[J]. 口腔疾病防治, 2020, 28(1): 11-15.
doi: 10.12016/j.issn.2096-1456.2020.01.002
|
[11] |
龚衍吉, 杨文宾. 关节腔药物注射治疗颞下颌关节骨关节炎的研究进展[J]. 临床口腔医学杂志, 2020, 36(7): 437-440.
|
[12] |
Montaseri A, Busch F, Mobasheri A, et al. IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: Involvement of Src/PI-3K/AKT pathway[J]. PLoS One, 2011, 6(12): e28663.
doi: 10.1371/journal.pone.0028663
URL
|
[13] |
Ornitz DM, Marie PJ. Fibroblast growth factor signaling in skeletal development and disease[J]. Genes Dev, 2015, 29(14): 1463-1486.
doi: 10.1101/gad.266551.115
URL
|
[14] |
Hegab AF, Ali HE, Elmasry M, et al. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis[J]. J Oral Maxillofac Surg, 2015, 73(9): 1706-1713.
doi: 10.1016/j.joms.2015.03.045
URL
|
[15] |
Hancı M, Karamese M, Tosun Z, et al. Intra-articular platelet-rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis[J]. J Craniomaxillofac Surg, 2015, 43(1): 162-166.
doi: 10.1016/j.jcms.2014.11.002
pmid: 25491276
|
[16] |
Cömert Kiliç S, Güngörmüş M, Sümbüllü MA. Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis alone in the treatment of temporomandibular joint osteoarthritis? A randomized clinical trial[J]. J Oral Maxillofac Surg, 2015, 73(8): 1473-1483.
doi: 10.1016/j.joms.2015.02.026
URL
|
[17] |
Kim JY, Kim BJ, Park KH, et al. Comparison of volume and position of the temporomandibular joint structures in patients with mandibular asymmetry[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2016, 122(6): 772-780.
doi: 10.1016/j.oooo.2016.08.017
URL
|